Novel dendritic cell-based vaccination in late stage melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-01-01 / Hum Vaccin Immunother 2014;10(11):3132-8Dendritic cell immunotherapy in uterine cancer
/in Dendritic Cells, Endometrial Cancer, International Publications /von 2014-01-01 / Hum Vaccin Immunother 2014;10(7):1822-7Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
/in Acute Leukemia, Dendritic Cells, International Publications, Multiple Myeloma /von 2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-31Diffuse intrinsic pontine glioma: time for therapeutic optimism
/in Brain Tumors in Children, International Publications /von 2014-01-01 / CNS Oncol 2014;3(5):337-48Tumor cell lysates as immunogenic sources for cancer vaccine design
/in Dendritic Cells, International Publications /von 2014-01-01 / Hum Vaccin Immunother 2014;10(11):3261-9Antigen trapping by dendritic cells for antitumor therapy
/in Dendritic Cells, International Publications /von 2014-01-01 / Methods Mol. Biol. 2014;1139:33-40Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine
/in Dendritic Cells, International Publications /von 2014-01-01 / Methods Mol. Biol. 2014;1139:17-26Immunotherapy and lung cancer: current developments and novel targeted therapies
/in Dendritic Cells, International Publications, NSCLC /von 2014-01-01 / Immunotherapy 2014;6(11):1221-35Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
/in Dendritic Cells, International Publications /von 2013-12-13 / Front Immunol 2013 Dec;4:454IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de